Researchers
Radan, Milica
Results 61-74 of 74
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2020 | Erratum: Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2Receptor Ligands for Alzheimer's Disease (Journal of Medicinal Chemistry (2020) 63:7 (3610−3633) DOI: 10.1021/acs.jmedchem.9b02080) | Abás, Sònia; Rodríguez-Arévalo, Sergio; Bagán, Andrea; Griñán-Ferré, Christian; Vasilopoulou, Foteini; Brocos-Mosquera, Iria; Muguruza, Carolina; Pérez, Belén; Molins, Elies; Luque, F. Javier; | Other | Mp. category will be shown later |
| 2020 | A bicyclic α‑iminophosphonate improves cognitive decline in 5xFAD murine model | S. Rodríguez-Arévalo; S. Abás; A. Bagán; C. Griñán-Ferré; F. Vasilopoulou; I. Brocos-Mosquera; C. Muguruza; L. F. Callado; B. Pérez; J. Brea; | Conference Paper | Mp. category will be shown later |
| 2020 | Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies | Radan, Milica M. | Conference Paper | Mp. category will be shown later |
| 2020 | Benzofuranylimidazoles: synthesis, affinity for imidazoline I2 receptors and improvement in the cognition of 5xFAD mouse model | S. Rodriguez-Arévalo; A. Bagán; C. Griñán-Ferré; F. Vasilopoulou; M. Pallàs; I. Brocos-Mosquera; C. Muguruza; L. F. Callado; E. Hernández; M. J. García-Fuster; | Conference Paper | Mp. category will be shown later |
| 2020 | In silico Identification of Novel 5-HT2A Antagonists Supported with Ligand- and Target- Based Drug Design Methodologies | Radan, Milica | Article | 21M21 |
| 2019 | Structure and ligand based drug design strategies in the development of novel serotonin 5-HT2A receptor antagonists | Radan, Milica M. | Conference Paper | Mp. category will be shown later |
| 2019 | (2-Imidazolin-4-yl)phosphonates: Green Chemistry and Biology Walk Together | Andrea Bagán; Sònia Abás; Sergio Rodríguez-Arévalo; Gemma Rodríguez-Arévalo; Fotini Vasilopoulou; Christian Griñán-Ferré; Mercè Pallàs; Pilar Pérez-Lozano; Radan, Milica M. | Conference Paper | Mp. category will be shown later |
| 2019 | Combined 3D-QSAR modeling, molecular dynamics and molecular docking studies in rational drug design of novel 5-HT2A antagonists | Radan, Milica M. | Conference Paper | Mp. category will be shown later |
| 2019 | Rational drug design of novel 5-HT2A antagonists | Radan, Milica M. | Conference Paper | Mp. category will be shown later |
| 2019 | Preclinical data on (2-imidazolin-4-yl) phosphonates | Nikolić, Katarina M.
L. F. Callado; E. Hernández; J. M. García-Fuster; J. A. García-Sevilla; J. Brea; M. I. Loza; L. Naesens; C. Escolano;
| Conference Paper | Mp. category will be shown later |
| 2019 | Structure and ligand based drug design strategies in the development of novel serotonin 5-HTt2a receptor antagonists | Radan, Milica | Conference Paper | Mp. category will be shown later |
| 2018 | Combined ligand and structure-based approach in search for 5-HT2A receptor agonists and antagonists | Nikolić, Katarina M. | Conference Paper | Mp. category will be shown later |
| 2018 | Kompjuterski dizajn agonista i antognista 5‐HT2A receptora | Radan, Milica | Conference Paper | Mp. category will be shown later |
| 2017 | 3D-QSAR study and development of pharmacophore for serotonin 5-HT2A receptors agonists | Radan, Milica | Article | 53M53 |